What do GPs think about prescribing aspirin to prevent colorectal cancer in Lynch syndrome?

In this episode, we talk to Kelly Lloyd, who is a research fellow within the Leeds Institute of Health Sciences at the University of Leeds.Title of paper: A factorial randomised trial investigating factors influencing general practitioners’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a registered reportAvailable at: https://doi.org/10.3399/BJGP.2021.0610National Institute for Health and Care Excellence (NICE) guidance for England and Wales recommends daily aspirin for colorectal cancer prevention in people with Lynch syndrome, and it is likely that prescribing will occur in primary care. GPs may be reluctant to prescribe due to concerns about the side-effects, supporting evidence and lack of awareness of the NICE guidance. In a randomised factorial trial, providing GPs with information on these factors did not increase willingness to prescribe, or comfort discussing harms and benefits. Alternative strategies targeting multiple levels of prescribing behaviour among unwilling GPs may support prescribing.